Lmr Partners LLP Aerovate Therapeutics, Inc. Transaction History
Lmr Partners LLP
- $18.1 Billion
- Q3 2025
A detailed history of Lmr Partners LLP transactions in Aerovate Therapeutics, Inc. stock. As of the latest transaction made, Lmr Partners LLP holds 14,100 shares of AVTE stock, worth $37,788. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,100Holding current value
$37,788% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding AVTE
# of Institutions
3Shares Held
1.63MCall Options Held
0Put Options Held
0About Aerovate Therapeutics, Inc.
- Ticker AVTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,448,100
- Market Cap $65.5M
- Description
- Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which ...